OTCMKTS:TSOI Therapeutic Solutions International (TSOI) Stock Forecast, Price & News $0.0017 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$0.0014▼$0.001850-Day Range N/A52-Week Range$0.00▼$0.02Volume8.21 million shsAverage Volume12.50 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Therapeutic Solutions International (OTCMKTS:TSOI) StockTherapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, it develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.Read More TSOI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TSOI Stock News HeadlinesSeptember 29, 2023 | finance.yahoo.comTherapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic NeutrophilsSeptember 18, 2023 | finance.yahoo.comTherapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory BoardSeptember 29, 2023 | Behind the Markets (Ad)[BREAKING] Pentagon to Spend Billions on "Living Missile"Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!September 15, 2023 | finance.yahoo.comTherapeutic Solutions International Subsidiary Discloses Potential Solution to Immunotherapy Resistance in Cancer by "Healing Tumor" Before Killing ItSeptember 12, 2023 | markets.businessinsider.comWhat 6 Analyst Ratings Have To Say About Black Diamond TherapeuticSeptember 11, 2023 | finance.yahoo.comTherapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal DementiaAugust 21, 2023 | finance.yahoo.comFloraStilbene™ Demonstrates Synergy with Conventional Chemotherapy and Immunotherapy in Reducing Triple Negative Breast CancerAugust 16, 2023 | finance.yahoo.comTherapeutic Solutions International Subsidiary Allogen Biologics Inc. Successfully Manufactures JadiCell Master Cell Bank to Provide Cells for Right to Try Use and Phase III ARDS Clinical TrialSeptember 29, 2023 | Investor Place Media (Ad)Elon Musk May Have Just Changed EverythingQuantum computing, 3D Printing and Gene-Editing are 3 most disruptive pieces of technology in recent times. None compare to a project Elon Musk released which could mint the world’s first trillionaire. July 31, 2023 | finance.yahoo.comTherapeutic Solutions International Prevention Subsidiary Campbell Neurosciences Receives Notice of Allowance on Suicide Prevention Drug CandidateJuly 18, 2023 | finance.yahoo.comTherapeutic Solutions International Subsidiary Res Nova Bio Inc Discovers New Mechanism of Action for Breast Cancer Immunotherapy Adjuvant FloraStilbene™July 12, 2023 | finance.yahoo.comTherapeutic Solutions International Files for Orphan Drug Designation Use of JadiCell Adult Stem Cells for Treatment of Frontotemporal DementiaJuly 8, 2023 | benzinga.comAion Therapeutic Announces Director ResignationJune 28, 2023 | finance.yahoo.comPhilogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic ProteinJune 28, 2023 | finance.yahoo.comMicroba Commences Phase I Clinical Trial for IBD TherapeuticJune 26, 2023 | finance.yahoo.comTherapeutic Solutions International Files for Orphan Drug Designation Using JadiCell Adult Universal Donor Stem Cells for Treatment of Acute Respiratory Distress SyndromeJune 19, 2023 | wnewsj.comBales talks Therapeutic Riding Camp at Rotary meetingJune 16, 2023 | msn.comCarroll County Farm Museum hosts Therapeutic Recreation Day for individuals with disabilitiesJune 15, 2023 | finance.yahoo.comGlobal Therapeutic Respiratory Devices Market Report 2023: Rising Prevalence of Respiratory Diseases Driving GrowthJune 9, 2023 | finance.yahoo.comPruritus Therapeutic Global Market Report 2023June 7, 2023 | msn.comTherapeutic camp for kids offered in SulphurJune 6, 2023 | benzinga.comPharmStars Announces "Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface" Theme for its Fall 2023 AcceleratorMay 25, 2023 | finance.yahoo.comTherapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem CellsMay 22, 2023 | finance.yahoo.comTherapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing VirusesMay 15, 2023 | finance.yahoo.comTherapeutic Solutions International Spin-Off Res Nova Bio Partners with Cure Stat Rx to Manufacture First in Class Breast Cancer Immunotherapy Product FloraStilbene™May 11, 2023 | marketwatch.com2030, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market: Growth & StatisticsMay 9, 2023 | msn.comRecap: Black Diamond Therapeutic Q1 EarningsSee More Headlines Receive TSOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter. Email Address TSOI Company Calendar Today9/29/2023Next Earnings (Estimated)11/17/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TSOI CUSIP883378101 CIK1419051 Webtherapeuticsolutionsint.com Phone(760) 295-7208FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Timothy George Dixon (Age 65)Chairman, CEO, Pres & CFO Comp: $240kDr. Feng Lin M.D. (Age 52)Ph.D., Chief Scientific Officer Dr. James Drew Veltmeyer M.D. (Age 57)Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board Ms. Famela Ramos (Age 46)VP of Bus. Devel. Ms. Serena RobellaDirector of SalesKey Competitors3SBioOTCMKTS:TRSBF60 Degrees Pharmaceuticals, Inc. WarrantNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFAgentixOTCMKTS:AGTXView All Competitors TSOI Stock - Frequently Asked Questions How have TSOI shares performed in 2023? Therapeutic Solutions International's stock was trading at $0.0060 at the beginning of the year. Since then, TSOI stock has decreased by 71.7% and is now trading at $0.0017. View the best growth stocks for 2023 here. Are investors shorting Therapeutic Solutions International? Therapeutic Solutions International saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 131,200 shares, a decrease of 50.7% from the August 31st total of 266,100 shares. Based on an average trading volume of 17,776,900 shares, the days-to-cover ratio is presently 0.0 days. View Therapeutic Solutions International's Short Interest. When is Therapeutic Solutions International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, November 17th 2023. View our TSOI earnings forecast. What other stocks do shareholders of Therapeutic Solutions International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD). What is Therapeutic Solutions International's stock symbol? Therapeutic Solutions International trades on the OTCMKTS under the ticker symbol "TSOI." How do I buy shares of Therapeutic Solutions International? Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Therapeutic Solutions International's stock price today? One share of TSOI stock can currently be purchased for approximately $0.00. How can I contact Therapeutic Solutions International? Therapeutic Solutions International's mailing address is 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States. The official website for the company is therapeuticsolutionsint.com. The company can be reached via phone at (760) 295-7208. This page (OTCMKTS:TSOI) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Therapeutic Solutions International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.